Skip to content

The ArTCell project has received funding from the Horizon Europe programme under grant agreement Nº 101130715 🇪🇺

Vision

In the first step, ArTCell will provide a global solution in the field of cancer treatment, yet the long-term vision and applicability go far beyond:

Range of diseases

We also envision the future use of ArTCells to target a range of diseases, such as infectious or autoimmune diseases.

Personalize

Finally, since ArTCells will be manufacturable from predefined components, they will also offer a straightforward strategy to personalize treatment for patients with specific disease characteristics.